Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus sakei Probiotics for Dry Eye Syndrome
NCT04938908Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2021
- Primary completion
- Jun 2022
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of Lactobacillus sakei in dry eye syndrome (DED) (4 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Ocular Surface Disease Index at 4 weeks. Started Jul 2021; status: completed.
02
Drugs
Lactobacillus sakei
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04938908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04938908.